← Open Payments lookup

DEBRA SCHEXNAYDER: Open Payments

NPI 1073557872 · HARVEY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,173 in 56 payments from 13 companies in 2025. Trend: 2023 $1,120 · 2024 $1,291 · 2025 $1,173

Food & beverage: $1,173
CompanyPaymentsAmount
ABBVIE INC.17$263
Lilly USA, LLC12$250
AstraZeneca Pharmaceuticals LP9$196
COLOPLAST CORP1$111
Boehringer Ingelheim Pharmaceuticals, Inc.4$86
Bayer Healthcare Pharmaceuticals Inc.1$67
GlaxoSmithKline, LLC.3$54
PFIZER INC.3$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$28
Sumitomo Pharma America, Inc.1$20

Products named: MOUNJARO, BREZTRI, UBRELVY, Altis, ZEPBOUND, CREON, JARDIANCE, AIRSUPRA.

Industry payments across LA — which companies pay providers there.